erlotinib hydrochloride has been researched along with chelerythrine in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (chelerythrine) | Trials (chelerythrine) | Recent Studies (post-2010) (chelerythrine) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 1,115 | 1 | 269 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | chelerythrine (IC50) |
|---|---|---|---|
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 1.2 | |
| Cholinesterase | Homo sapiens (human) | 8.58 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.55 | |
| Acetylcholinesterase | Homo sapiens (human) | 1.45 | |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.566 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, M; Li, Y; Song, C; Yang, Z; Zhang, L; Zhang, X | 1 |
1 other study(ies) available for erlotinib hydrochloride and chelerythrine
| Article | Year |
|---|---|
Additive effects of cherlerythrine chloride combination with erlotinib in human non-small cell lung cancer cells.
Topics: Animals; Benzophenanthridines; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Therapy, Combination; ErbB Receptors; Erlotinib Hydrochloride; Flow Cytometry; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Phosphorylation; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |